Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease
- D. M. Harris (Speaker)
- A. Fisher (Speaker)
- A. J. Harkin (Speaker)
- Anthony E. Bolton (Speaker)
- Sullivan, A. (Speaker)
- Nolan, Y. (Speaker)
Activity: Talk or presentation › Invited talk